Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma

Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin

Clin Mol Hepatol. 2012;18(3):287-294. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.287

View: 7463 Download: 84 Crossref: 12

Liver Pathology

Early hepatocellular carcinoma

So-Young Jin, In Ho Choi

Clin Mol Hepatol. 2011;17(3):238-241. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.238

View: 5622 Download: 38 Crossref: 1

Cholangiocarcinoma arising in von Meyenburg complexes

Hee Kyung Kim, So-Young Jin

Clin Mol Hepatol. 2011;17(2):161-164. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.161

View: 5875 Download: 55 Crossref: 19

Sclerosed hemangioma of the liver

So-Young Jin

Clin Mol Hepatol. 2010;16(4):410-413. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.410

View: 7567 Download: 61 Crossref: 10

1 |

Viewed By 5315	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5264	MAFLD: How is it different from NAFLD?
Viewed By 5157	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3871	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3809	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search